- Home
- LWLG vs CRMD Comparison
LWLG vs CRMD Comparison
Compare LWLG & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LWLG | CRMD |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.9M | 590.7M |
| IPO Year | 2011 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LWLG | CRMD |
|---|---|---|
| Price | $4.14 | $7.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $9.00 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 3.4M | 986.9K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.79 | ★ 780.00 |
| EPS | N/A | ★ 0.72 |
| Revenue | $236,855.00 | ★ $311,709,000.00 |
| Revenue This Year | N/A | $8.13 |
| Revenue Next Year | $998.56 | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | 147.74 | ★ 617.03 |
| 52 Week Low | $2.84 | $6.13 |
| 52 Week High | $18.71 | $13.02 |
Technical Indicators
Market Signals| Indicator | LWLG | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 57.54 |
| Support Level | $3.80 | $7.08 |
| Resistance Level | $5.73 | $9.01 |
| Average True Range (ATR) | 0.35 | 0.27 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 22.19 | 78.82 |
Price Performance
Historical ComparisonAbout LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.